Skip to main content
. 2020 Mar 5;59(8):1027–1036. doi: 10.1007/s40262-020-00873-3
A unified cefepime population pharmacokinetic model has been developed from adult and pediatric patients and evaluates well in independent populations.
When paired with real-time β-lactam assays, a precision dosing approach will optimize drug exposure and improve clinical outcomes.